Hyperthermia

Clinical Radiation Oncology: Third Edition

Volumn , Issue , 2012, Pages 385-403

  Dewhirst, Mark ^a   Das, Shiva ^a   Stauffer, Paul ^a   Craciunescu, Oana ^a   Vujaskovic, Zeljko ^a   Thrall, Donald ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893065279     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1637-5.00021-3     Document Type: Chapter

References (275)

1. Arrhenius S Uber die reaktionsgeschwindigkeit bei der inversion von rohrzucker durch Sauren. Zeitschr Physik Chem 1889, 4:226-248.
2. Sapareto SA, Dewey WC Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984, 10(6):787-800.
3. Dewhirst MW, Viglianti BL, Lora-Michiels M Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003, 19(3):267-294.
4. Morimoto RI, Kroeger PE, Cotto JJ The transcriptional regulation of heat shock genes. A plethora of heat shock factors and regulatory conditions. Exs 1996, 77:139-163.
5. Raaphorst G Fundamental aspects of hyperthermic biology. An introduction to the practical aspects of clinical hyperthermia 1990, 10-54. Taylor and Francis, London. S. Field, J. Hand (Eds.).
6. Coss RA, Linnemans WA The effects of hyperthermia on the cytoskeleton. A review. Int J Hyperthermia 1996, 12(2):173-196.
7. Pratt WB, Silverstein AM, Galigniana MD A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37. Cell Signal 1999, 11(12):839-851.
8. Liang P, MacRae TH Molecular chaperones and the cytoskeleton. J Cell Sci 1997, 110(Part 13):1431-1440.
9. Streffer C Metabolic changes during and after hyperthermia. Int J Hyperthermia 1985, 1(4):305-319.
10. Vidair CA, Doxsey SJ, Dewey WC Heat shock alters centrosome organization leading to mitotic dysfunction and cell death. J Cell Physiol 1993, 154(3):443-455.
11. Kampinga HH, Dikomey E Hyperthermic radiosensitization. Mode of action and clinical relevance. Int J Radiat Biol 2001, 77(4):399-408.
12. Dewhirst MW, Sim D, Gross J, Kundrat M Effects of heating rate on normal and tumor microcirculatory function. Heat and mass transfer in the microcirculation of thermally significant vessels, Anaheim 1986, 75-80. ASME, California. K. Diller, R.B. Roemer (Eds.).
13. Song CW Effect of local hyperthermia on blood flow and microenvironment. A review. Cancer Res 1984, 44(10 Suppl):4721s-4730s.
14. Reinhold HS Physiological effects of hyperthermia. Recent Results Cancer Res 1988, 107:32-43.
15. Kong G, Braun RD, Dewhirst MW Hyperthermia enables tumor-specific nanoparticle delivery. Effect of particle size. Cancer Res 2000, 60(16):4440-4445.
16. Kong G, Braun RD, Dewhirst MW Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature. Cancer Res 2001, 61(7):3027-3032.
17. Matteucci ML, Anyarambhatla G, Rosner G, et al. Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 2000, 6(9):3748-3755.
18. Krol A, Dewhirst MW, Yuan F Effects of cell damage and glycosaminoglycan degradation on available extravascular space. Int J Hyperthermia 2003, 19(2):154-164.
19. Kong G, Dewhirst MW Hyperthermia and liposomes. Int J Hyperthermia 1999, 15(5):345-370.
20. Kouloulias VE, Dardoufas CE, Kouvaris JR, et al. Liposomal doxorubicin in conjunction with reirradiation and local hyperthermia treatment in recurrent breast cancer. A phase I/II trial. Clin Cancer Res 2002, 8(2):374-382.
21. Dahl O Interaction of heat and drugs in vitro and in vivo. Thermoradiotherapy and thermochemotherapy 1995, 103-155. Springer-Verlag, Berlin. M. Seegenschmiedt, P. Fessenden, C. Vernon (Eds.).
22. Curry FE Determinants of capillary permeability. A review of mechanisms based on single capillary studies in the frog. Circ Res 1986, 59(4):367-380.
23. Hauck M, Zalutsky M, Dewhirst MW Enhancement of radiolabeled monoclonal antibody uptake in tumors with local hyperthermia. Targeted delivery of imaging agents 1995, 335-361. CRC Press, Boca raton, Florida. V. Torchilin (Ed.).
24. Meyer DE, Kong GA, Dewhirst MW, et al. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. Cancer Res 2001, 61(4):1548-1554.
25. Dreher MR, Liu W, Michelich CR, et al. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 2007, 67(9):4418-4424.
26. Dreher MR, Elas M, Ichikawa K, et al. Nitroxide conjugate of a thermally responsive elastin-like polypeptide for non-invasive thermometry. Med Phys 2004, 31(10):2755-2762.
27. Prescott DM, Charles HC, Sostman HD, et al. Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopy. Int J Radiat Oncol Biol Phys 1994, 28(2):415-423.
28. Sijens PE, Bovee WM, Seijkens D, et al. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo 31P-nuclear magnetic resonance spectroscopy. Cancer Res 1987, 47(24 Part 1):6467-6473.
29. Kelleher DK, Engel T, Vaupel PW Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 1995, 11(2):241-255.
30. Oleson JR Eugene Robinson Special Lecture. Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia 1995, 11(3):315-322.
31. Song CW, Park H, Griffin RJ Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001, 155(4):515-528.
32. Sun X, Xing L, Ling CC, Li GC The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion. Relevance for radiotherapy, vascular targeting and imaging. Int J Hyperthermia 2010, 26(3):224-231.
33. Vujaskovic Z, Poulson J, Gaskin A, et al. Temperature dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia. Int J Radiat Oncol Biol Phys 2000, 46(1):179-185.
34. Brizel DM, Scully SP, Harrelson JM, et al. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res 1996, 56(23):5347-5350.
35. Jones EL, Prosnitz LR, Dewhirst MW, et al. Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer. Clin Cancer Res 2004, 10(13):4287-4293.
36. Dewhirst MW, Thrall DE, Palmer G, et al. Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy. Int J Hyperthermia 2010, 26(3):283-293.
37. Griffin RJ, Ogawa A, Williams BW, Song CW Hyperthermic enhancement of tumor radiosensitization strategies. Immunol Invest 2005, 34(3):343-359.
38. Okajima K, Griffin RJ, Iwata K, et al. Tumor oxygenation after mild-temperature hyperthermia in combination with carbogen breathing. Dependence on heat dose and tumor type. Radiat Res 1998, 149(3):294-299.
39. Wahl ML, Bobyock SB, Leeper DB, Owen CS Effects of 42 degrees C hyperthermia on intracellular pH in ovarian carcinoma cells during acute or chronic exposure to low extracellular pH. Int J Radiat Oncol Biol Phys 1997, 39(1):205-212.
40. Coss RA, Storck CW, Wachsberger PR, et al. Acute extracellular acidification reduces intracellular pH, 42 degrees C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. Int J Hyperthermia 2004, 20(1):93-106.
41. Crabtree H LXI. Observations on the carbohydrate metabolism of tumours. Biochem J 1929, 23:536-545.
42. Newsholme E, Crabtree B, Ardawi M The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 1985, 5:393-400.
43. Leeper DB, Engin K, Thistlethwaite AJ, et al. Human tumor extracellular pH as a function of blood glucose concentration. Int J Radiat Oncol Biol Phys 1994, 28(4):935-943.
44. Prescott DM, Charles HC, Sostman HD, et al. Manipulation of intra-and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int J Hyperthermia 1993, 9(5):745-754.
45. Biaglow JE, Manevich Y, Leeper D, et al. MIBG inhibits respiration. Potential for radio-and hyperthermic sensitization. Int J Radiat Oncol Biol Phys 1998, 42(4):871-876.
46. Zhou R, Bansal N, Leeper DB, Glickson JD Intracellular acidification of human melanoma xenografts by the respiratory inhibitor m-iodobenzylguanidine plus hyperglycemia. A 31P magnetic resonance spectroscopy study. Cancer Res 2000, 60(13):3532-3536.
47. Wachsberger PR, Burd R, Bhala A, et al. Quercetin sensitizes cells in a tumour-like low pH environment to hyperthermia. Int J Hyperthermia 2003, 19(5):507-519.
48. Asea A, Ara G, Teicher BA, et al. Effects of the flavonoid drug quercetin on the response of human prostate tumours to hyperthermia in vitro and in vivo. Int J Hyperthermia 2001, 17(4):347-356.
49. Jones EL, Zhao M, Stevenson MA, Calderwood SK The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. Int J Hyperthermia 2004, 20(8):835-849.
50. Song CW, Kim GE, Lyons JC, et al. Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys 1994, 30(5):1161-1169.
51. Nathanson SD, Cerra RF, Hetzel FW, et al. Changes associated with metastasis in B16-F1 melanoma cells surviving heat. Arch Surg 1990, 125(2):216-219.
52. Nathanson SD, Nelson L, Anaya P, et al. Development of lymph node and pulmonary metastases after local irradiation and hyperthermia of footpad melanomas. Clin Exp Metastasis 1991, 9(4):377-392.
53. Hill SA, Denekamp J Does local tumour heating in mice influence metastatic spread?. Br J Radiol 1982, 55(654):444-451.
54. Baker DG, Sager H, Constable WC, Goodchild NT Influence of ultrasound-induced hyperthermia and X-irradiation on the incidence of metastases from a solid tumor. Invasion Metastasis 1984, 4(2):111-124.
55. Dewhirst MW, Sim DA, Forsyth K, et al. Local control and distant metastases in primary canine malignant melanomas treated with hyperthermia and/or radiotherapy. Int J Hyperthermia 1985, 1(3):219-234.
56. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996, 12(1):3-20.
57. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet 1995, 345(8949):540-543.
58. Gillette SM, Dewhirst MW, Gillette EL, et al. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia. A randomized phase II study. Int J Hyperthermia 1992, 8(3):309-320.
59. Maguire PD, Samulski TV, Prosnitz LR, et al. A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. Int J Hyperthermia 2001, 17(4):283-290.
60. Pisters WT, O'Sullivan BO, Demetri GD Sarcomas of nonosseous tissues. Cancer medicine 2000, 1906-1930. B.C. Decker, Hamilton, Ontario. 5th ed. R.C. Bast, D.W. Kufe, R.E. Pollack (Eds.).
61. Engin K, Leeper D, Thistlethwaite A, et al. Tumor extracellular pH as a prognostic factor in thermoradiotherapy. Int J Radiat Oncol Biol Phys 1994, 29:125-132.
62. Mivechi NF, Dewey WC DNA polymerase alpha and beta activities during the cell cycle and their role in heat radiosensitization in Chinese hamster ovary cells. Radiat Res 1985, 103(3):337-350.
63. Raaphorst GP, Ng CE, Yang DP Thermal radiosensitization and repair inhibition in human melanoma cells. A comparison of survival and DNA double strand breaks. Int J Hyperthermia 1999, 15(1):17-27.
64. Raaphorst GP, Yang DP, Ng CE Effect of protracted mild hyperthermia on polymerase activity in a human melanoma cell line. Int J Hyperthermia 1994, 10(6):827-834.
65. Overgaard J The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989, 16(3):535-549.
66. Dewhirst MW, Sim DA The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia. Cancer Res 1984, 44(10 Suppl):4772s-4780s.
67. Gillette EL, McChesney SL, Dewhirst MW, Scott RJ Response of canine oral carcinomas to heat and radiation. Int J Radiat Oncol Biol Phys 1987, 13(12):1861-1867.
68. Denman DL, Legorreta RA, Kier AB, et al. Therapeutic responses of spontaneous canine malignancies to combinations of radiotherapy and hyperthermia. Int J Radiat Oncol Biol Phys 1991, 21(2):415-422.
69. Kapp DS, Cox RS, Fessenden P, et al. Parameters predictive for complications of treatment with combined hyperthermia and radiation therapy. Int J Radiat Oncol Biol Phys 1992, 22(5):999-1008.
70. Wiggenraad R, Koning C, Westermann C, et al. Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma. Int J Hyperthermia 2005, 21(3):185-192.
71. Matthews KS, Rocconi RP, Straughn JM Complete uterine necrosis following chemoradiation for advanced cervical cancer. A case report. Gynecol Oncol 2007, 106(1):265-267.
72. Marnitz S, Kohler C, Fuller J, et al. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol 2006, 182(1):45-51.
73. Hettinga JV, Konings AW, Kampinga HH Reduction of cellular cisplatin resistance by hyperthermia-a review. Int J Hyperthermia 1997, 13(5):439-457.
74. Laskowitz DT, Elion GB, Dewhirst MW, et al. Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft. Radiat Res 1992, 129(2):218-223.
75. Da Silva VF, Feeley M, Raaphorst GP Hyperthermic potentiation of BCNU toxicity in BCNU-resistant human glioma cells. J Neurooncol 1991, 11(1):37-41.
76. Averill DA, Su C Sensitization to the cytotoxicity of adriamycin by verapamil and heat in multidrug-resistant Chinese hamster ovary cells. Radiat Res 1999, 151(6):694-702.
77. Herman TS, Teicher BA, Varshney A, et al. Effect of hypoxia and acidosis on the cytotoxicity of mitoxantrone, bisantrene and amsacrine and their platinum complexes at normal and hyperthermic temperatures. Anticancer Res 1992, 12(3):827-836.
78. Teicher BA, Holden SA, Rudolph MB, et al. Effect of environmental conditions (pH, oxygenation and temperature) on the cytotoxicity of flavone acetic acid and its dimethylaminoethyl ester. Int J Hyperthermia 1991, 7(6):905-915.
79. Teicher BA, Herman TS, Holden SA, Rudolph MB Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma. Cancer Lett 1991, 59(2):109-117.
80. Holden SA, Teicher BA, Herman TS Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma. Int J Radiat Oncol Biol Phys 1991, 20(5):1031-1038.
81. Teicher BA, Herman TS, Holden SA Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole. Int J Radiat Oncol Biol Phys 1991, 20(4):723-731.
82. Tabuchi Y, Takasaki I, Wada S, et al. Genes and genetic networks responsive to mild hyperthermia in human lymphoma U937 cells. Int J Hyperthermia 2008, 24(8):613-622.
83. Furusawa Y, Tabuchi Y, Takasaki I, et al. Gene networks involved in apoptosis induced by hyperthermia in human lymphoma U937 cells. Cell Biol Int 2009, 33(12):1253-1262.
84. Borkamo ED, Dahl O, Bruland O, Fluge O Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. Int J Hyperthermia 2009, 25(1):41-46.
85. Borkamo ED, Dahl O, Bruland O, Fluge O Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model. Int J Hyperthermia 2008, 24(5):425-441.
86. Nivon M, Richet E, Codogno P, et al. Autophagy activation by NF kappa B is essential for cell survival after heat shock. Autophagy 2009, 5(6):766-783.
87. Chen F, Wang CC, Kim E, Harrison LE Hyperthermia in combination with oxidative stress induces autophagic cell death in HT-29 colon cancer cells. Cell Biol Int 2008, 32(7):715-723.
88. Pajonk F, van Ophoven A, McBride WH Hyperthermia-induced proteasome inhibition and loss of androgen receptor expression in human prostate cancer cells. Cancer Res 2005, 65(11):4836-4843.
89. Kullberg M, Mann K, Owens JL A two-component drug delivery system using Her-2-targeting thermosensitive liposomes. J Drug Targeting 2009, 17(2):98-107.
90. Wuang SC, Neoh KG, Kang ET, et al. HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization. Biomaterials 2008, 29(14):2270-2279.
91. Sawant RM, Sawant RR, Gultepe E, et al. Nanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticles. J Nanoparticle Res 2009, 11(7):1777-1785.
92. Huang YF, Sefah K, Bamrungsap S, et al. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 2008, 24(20):11860-11865.
93. Urano M, Kuroda M, Nishimura Y For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999, 15(2):79-107.
94. Katschinski DM, Robins HI Hyperthermic modulation of SN-38-induced topoisomerase I DNA cross-linking and SN-38 cytotoxicity through altered topoisomerase I activity. Int J Cancer 1999, 80(1):104-109.
95. Ng CE, Bussey AM, Raaphorst GP Sequence of treatment is important in the modification of camptothecin induced cell killing by hyperthermia. Int J Hyperthermia 1996, 12(5):663-678. discussion Int J Hyperthermia 12(5):679-680, 1996.
96. Leal BZ, Meltz ML, Mohan N, et al. Interaction of hyperthermia with Taxol in human MCF-7 breast adenocarcinoma cells. Int J Hyperthermia 1999, 15(3):225-236.
97. Cividalli A, Cruciani G, Livdi E, et al. Hyperthermia enhances the response of paclitaxel and radiation in a mouse adenocarcinoma. Int J Radiat Oncol Biol Phys 1999, 44(2):407-412.
98. Vaden SL, Page RL, Williams PL, Riviere JE Effect of hyperthermia on cisplatin and carboplatin disposition in the isolated, perfused tumour and skin flap. Int J Hyperthermia 1994, 10(4):563-572.
99. Kido Y, Kuwano H, Maehara Y, et al. Increased cytotoxicity of low-dose, long-duration exposure to 5-fluorouracil of V-79 cells with hyperthermia. Cancer Chemother Pharmacol 1991, 28(4):251-254.
100. Ostberg JR, Kabingu E, Repasky EA Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia 2007, 19(5):520-533.
101. Menoret A, Chaillot D, Callahan M, Jacquin C Hsp70, an immunological actor playing with the intracellular self under oxidative stress. Int J Hyperthermia 2002, 18:490-505.
102. Manjili MH, Wang XY, Park J, et al. Cancer immunotherapy. Stress proteins and hyperthermia. Int J Hyperthermia 2002, 18:506-520.
103. Multhoff G Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002, 18:576-585.
104. Shah A, Unger E, Bain MD, et al. Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermia. Int J Hyperthermia 2002, 18:534-551.
105. Asea A, Kabingu E, Stevenson MA, Calderwood SK HSP70 peptidembearing and peptide-negative preparations act as chaperokines. Cell Stress Chaperones 2000, 5(5):425-431.
106. Hand JR Physical techniques in clinical hyperthermia 1986, John Wiley and Sons, New York.
107. Cossett JM Interstitial, endocavitary, and perfusional hyperthermia 1990, Springer-Verlag, Berlin.
108. Fessenden P, Hand JW Hyperthermia therapy physics. Medical radiology: radiation therapy physics 1995, 315-363. Springer-Verlag, Berlin, Heidelberg. A.R. Smith (Ed.).
109. Hand JW Biophysics and technology of electromagnetic hyperthermia. Methods of external hyperthermia heating 1990, 1-60. Springer-Verlag, Berlin, Heidelberg. M. Gautherie (Ed.).
110. Hynynen K Ultrasound heating technology. Thermoradiotherapy and thermochemotherapy 1995, 253-277. Springer-Verlag, Berlin, Heidelberg. M.H. Seegenschmiedt, P. Fessenden, C.C. Vernon (Eds.).
111. Lee ER Electromagnetic superficial heating technology. Thermoradiotherapy and thermochemotherapy 1995, 193-217. Springer-Verlag, Berlin, Heidelberg. M.H. Seegenschmiedt, P. Fessenden, C.C. Vernon (Eds.).
112. Stauffer PR Evolving technology for thermal therapy of cancer. Int J Hyperthermia 2005, 21(8):731-744.
113. Stauffer PR, Diederich CJ, Seegenschmiedt MH Interstitial heating technologies. Thermoradiotherapy and thermochemotherapy. Vol. 1. Biology, physiology and physics 1995, 279-320. Springer-Verlag, Berlin, New York. M.H. Seegenschmiedt, P. Fessenden, C.C. Vernon (Eds.).
114. Stauffer PR, Diederich CJ, Pouliot J Thermal therapy for cancer. Brachytherapy Physics 2005, 901-932. Joint AAPM/ABS Summer School, Med Phys Monograph No. 31. 2nd ed. B. Thomadsen, M. Rivard, W. Butler (Eds.).
115. Rhee JG, Lee CK, Osborn J, et al. Precooling prevents overheating of subcutaneous fat in the use of RF capacitive heating. Int J Radiat Oncol Biol Phys 1991, 20(5):1009-1015.
116. Kroeze H, van de Kamer JB, de Leeuw AA, et al. Treatment planning for capacitive regional hyperthermia. Int J Hyperthermia 2003, 19(1):58-73.
117. Ohguri T, Imada H, Yahara K, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer. The radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int J Radiat Oncol Biol Phys 2009, 73(1):128-135.
118. Maehara Y, Kuwano H, Kitamura K, et al. Hyperthermochemoradiotherapy for esophageal cancer (review). Anticancer Res 1992, 12(3):805-810.
119. Nadobny J, Wlodarczyk W, Westhoff L, et al. Development and evaluation of a three-dimensional hyperthermia applicator with Water-COated Antennas (WACOA). Med Phys 2003, 30(8):2052-2064.
120. Turner PF Regional hyperthermia with an annular phased array. IEEE Trans Biomed Eng 1984, 31:106-114.
121. van Dijk JDP, Schneider C, van Os R, et al. Results of deep body hyperthermia with large waveguide radiators. Adv Exp Med Biol 1990, 267:315-319.
122. Van Es CA, Wyrdeman HK, de Leeuw AA, et al. Regional hyperthermia of pelvic tumours using the Utrecht "Coaxial TEM" system. A feasibility study. Int J Hyperthermia 1995, 11(2):173-186.
123. Dewhirst MW, Samulski TV Hyperthermia in the treatment of cancer 1988, (Current Concepts Monograph.), Michigan, Upjohn, Kalamazoo.
124. Samulski TV, Grant WJ, Oleson JR, et al. Clinical experience with a multi-element ultrasonic hyperthermia system. Analysis of treatment temperatures. Int J Hyperthermia 1990, 6(5):909-922.
125. Moros EG, Fan X, Straube WL Experimental assessment of power and temperature penetration depth control with a dual frequency ultrasonic system. Med Phys 1999, 26(5):810-817.
126. Novak P, Penagaricano JA, Nahirnyak V, et al. Influence of the SURLAS applicator on radiation dose distributions during simultaneous thermoradiotherapy with helical tomotherapy. Phys Med Biol 2008, 53(10):2509-2522.
127. Hynynen K, Roemer R, Anhalt D, et al. A scanned, focused, multiple transducer ultrasonic system for localized hyperthermia treatments. Int J Hyperthermia 1987, 3(1):21-35.
128. Hynynen K, McDannold N MRI guided and monitored focused ultrasound thermal ablation methods: a review of progress. Int J Hyperthermia 2004, 20(7):725-737.
129. Cetas TC Thermometry. An introduction to the practical aspects of clinical hyperthermia 1990, 423-477. Taylor & Francis, London, New York. S.B. Field, J.W. Hand (Eds.).
130. Dewhirst MW, Phillips TL, Samulski TV, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990, 18(5):1249-1259.
131. Dewhirst MW Thermal dosimetry. Thermoradiotherapy and thermochemotherapy 1995, 123-128. Springer-Verlag, Berlin. M. Seegenschmiedt, P. Fessenden, C.C. Vernon (Eds.).
132. Edelstein-Keshet L, Dewhirst MW, Oleson JR, Samulski TV Characterization of tumour temperature distributions in hyperthermia based on assumed mathematical forms. Int J Hyperthermia 1989, 5(6):757-777.
133. Dewhirst MW, Winget JM, Edelstein-Keshet L, et al. Clinical application of thermal isoeffect dose. Int J Hyperthermia 1987, 3(4):307-318.
134. Tilly W, Wust P, Rau B, et al. Temperature data and specific absorption rates in pelvic tumours: predictive factors and correlations. Int J Hyperthermia 2001, 17(2):172-188.
135. Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys 1998, 41(5):1129-1137.
136. Waterman FM, Dewhirst MW, Fessenden P, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia administered by ultrasound. Int J Radiat Oncol Biol Phys 1991, 20(5):1099-1107.
137. Emami B, Stauffer P, Dewhirst MW, et al. RTOG quality assurance guidelines for interstitial hyperthermia. Int J Radiat Oncol Biol Phys 1991, 20(5):1117-1124.
138. Sapozink MD, Corry PM, Kapp DS, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia for deep-seated malignancy. Int J Radiat Oncol Biol Phys 1991, 20(5):1109-1115.
139. Hand JW, Machin D, Vernon CC, Whaley JB Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hyperthermia 1997, 13(4):343-364.
140. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005, 23(13):3079-3085.
141. Kapp DS, Cox RS Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast. Int J Radiat Oncol Biol Phys 1995, 33(4):887-899.
142. Oleson JR, Samulski TV, Leopold KA, et al. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993, 25(2):289-297.
143. Seegenschmiedt MH, Martus P, Fietkau R, et al. Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT). Tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys 1994, 29(5):1049-1063.
144. Sherar M, Liu FF, Pintilie M, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 1997, 39(2):371-380.
145. Cetas TC Practical thermometry with a thermographic camera-calibration, transmittance, and emittance measurements. Rev Sci Instrum 1978, 49(2):245-254.
146. Arunachalam K, Maccarini P, Juang T, et al. Performance evaluation of a conformal thermal monitoring sheet sensor array for measurement of surface temperature distributions during superficial hyperthermia treatments. Int J Hyperthermia 2008, 24(4):313-325.
147. Arunachalam K, Maccarini PF, Stauffer PR A thermal monitoring sheet with low influence from adjacent waterbolus for tissue surface thermometry during clinical hyperthermia. IEEE Trans Biomed Eng 2008, 55(10):2397-2406.
148. Thermal dosimetry and treatment planning 1990, Springer-Verlag, Berlin, Heidelberg. M. Gautherie (Ed.).
149. Paulsen KD, Moskowitz MJ, Ryan TP, et al. Initial in vivo experience with EIT as a thermal estimator during hyperthermia. Int J Hyperthermia 1996, 12(5):573-591. discussion Int J Hyperthermia 12(5):593-594, 1996.
150. Arthur RM, Straube WL, Trobaugh JW, Moros EG In vivo change in ultrasonic backscattered energy with temperature in motion-compensated images. Int J Hyperthermia 2008, 24(5):389-398.
151. Trobaugh JW, Arthur RM, Straube WL, Moros EG A simulation model for ultrasonic temperature imaging using change in backscattered energy. Ultrasound Med Biol 2008, 34(2):289-298.
152. Meaney PM, Zhou T, Fanning MW, et al. Microwave thermal imaging of scanned focused ultrasound heating. Phantom results. Int J Hyperthermia 2008, 24(7):523-536.
153. Arunachalam K, Stauffer PR, Maccarini PF, et al. Characterization of a digital microwave radiometry system for noninvasive thermometry using a temperature-controlled homogeneous test load. Phys Med Biol 2008, 53(14):3883-3901.
154. Bardati F, Brown VJ, Tognolatti P Temperature reconstructions in a dielectric cylinder by multi-frequency microwave radiometry. J Electromagn Waves Appl 1993, 7(11):1549-1571.
155. Dubois L, Sozanski JP, Tessier V, et al. Temperature control and thermal dosimetry by microwave radiometry in hyperthermia. IEEE Trans Microwave Theory Tech 1996, 44(10, Part.2):1755-1761.
156. Hand JW, Van Leeuwen GMJ, Mizushina S, et al. Monitoring of deep brain temperature in infants using multi-frequency microwave radiometry and thermal modelling. Phys Med Biol 2001, 46(7):1885-1903.
157. Jacobsen S, Stauffer P Non-invasive temperature profile estimation in a lossy medium based on multi-band radiometric signals sensed by a microwave dual-purpose body-contacting antenna. Int J Hyperthermia 2002, 18(2):86-103.
158. Jacobsen S, Stauffer PR Can we settle with single-band radiometric temperature monitoring during hyperthermia treatment of chestwall recurrence of breast cancer using a dual-mode transceiving applicator?. Phys Med Biol 2007, 52(4):911-928.
159. Mizushina S, Shimizu T, Suzuki K, et al. Retrieval of temperature-depth profiles in biological objects from multi-frequency microwave radiometric data. J Electromagn Waves Appl 1993, 7(11):1515-1548.
160. Gellermann J, Wlodarczyk W, Ganter H, et al. A practical approach to thermography in a hyperthermia/magnetic resonance hybrid system. Validation in a heterogeneous phantom. Int J Radiat Oncol Biol Phys 2005, 61(1):267-277.
161. MacFall J, Soher B From the RSNA refresher courses. MR imaging in hyperthermia. Radiographics 2007, 27:1809-1818.
162. McDannold N Quantitative MRI-based temperature mapping based on the proton resonant frequency shift. Review of validation studies. Int J Hyperthermia 2005, 21(6):533-546.
163. Soher B, Wyatt C, Reeder S, MacFall J Noninvasive temperature mapping with MRI using chemical shift water-fat separation. Magn Res Med 2010, 63(5):1238-1246.
164. Wyatt C, Soher B, Maccarini P, et al. Hyperthermia MRI temperature measurement. Evaluation of measurement stabilisation strategies for extremity and breast tumours. Int J Hyperthermia 2009, 25(6):422-433.
165. Craciunescu OI, Stauffer PR, Soher BJ, et al. Accuracy of real time noninvasive temperature measurements using magnetic resonance thermal imaging in patients treated for high grade extremity soft tissue sarcomas. Med Phys 2009, 36(11):4848-4858.
166. Gellermann J, Weihrauch M, Cho CH, et al. Comparison of MR-thermography and planning calculations in phantoms. Med Phys 2006, 33(10):3912-3920.
167. Li Z, Vogel M, Maccarini P, et al. Towards the validation of a commercial hyperthermia treatment planning system (invited paper). Microwave J 2008, 51(12):28-42.
168. Li Z, Vogel M, Maccarini P, et al. Improved thermal planning and treatment control using SAR/temperature simulation and PRFS magnetic resonance thermal imaging. Int J Hyperthermia 2011, 27(1):86-89.
169. Cheng KS, Stakhursky V, Craciunescu OI, et al. Fast temperature optimization of multi-source hyperthermia applicators with reduced-order modeling of 'virtual sources'. Phys Med Biol 2008, 53(6):1619-1635.
170. Hutchinson E, Dahleh M, Hynynen K The feasibility of MRI feedback control for intracavitary phased array hyperthermia treatments. Int J Hyperthermia 1998, 14(1):39-56.
171. Stakhursky VL, Arabe O, Cheng KS, et al. Real-time MRI-guided hyperthermia treatment using a fast adaptive algorithm. Phys Med Biol 2009, 54(7):2131-2145.
172. Stauffer P, Craciunescu O, Maccarini P, et al. Clinical utility of magnetic resonance thermal imaging (mrti) for realtime guidance of deep hyperthermia. Conference proceedings of the SPIE, 2009 2009, 7181OI-1-12. SPIE Press, Bellingham Washington. T. Ryan (Ed.).
173. Cline HE, Hynynen K, Schneider E, et al. Simultaneous magnetic resonance phase and magnitude temperature maps in muscle. Magn Reson Med 1996, 35(3):309-315.
174. McDannold N, Hynynen K Quality assurance and system stability of a clinical MRI-guided focused ultrasound system. Four-year experience. Med Phys 2006, 33(11):4307-4313.
175. Kinsey AM, Diederich CJ, Rieke V, et al. Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy. In vivo evaluation under MR guidance. Med Phys 2008, 35(5):2081-2093.
176. van Rhoon GC, Wust P Introduction: non-invasive thermometry for thermotherapy. Int J Hyperthermia 2005, 21(6):489-495.
177. Gellerman J, Wlodarczyk W, Feussner A, et al. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia 2005, 21(6):497-513.
178. Kuroda K Non-invasive MR thermography using the water proton chemical shift. Int J Hyperthermia 2005, 21(6):547-560.
179. Rieke V, Butts PK MR thermometry. J Magn Reson Imaging 2008, 27(2):376-390.
180. Meyer JL The clinical efficacy of localized hyperthermia. Cancer Res 1984, 44(10 Suppl):4745s-4751s.
181. Dewhirst MW, Connor WG, Sim DA Preliminary results of a phase III trial of spontaneous animal tumors to heat and/or radiation. Early normal tissue response and tumor volume influence on initial response. Int J Radiat Oncol Biol Phys 1982, 8(11):1951-1961.
182. Falk MH, Issels RD Hyperthermia in oncology. Int J Hyperthermia 2001, 17(1):1-18.
183. Issels RD, Abdel-Rahman S, Wendtner C, et al. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. Eur J Cancer 2001, 37(13):1599-1608.
184. Sugimachi K, Kuwano H, Ide H, et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma. A prospective randomized trial. Int J Hyperthermia 1994, 10(4):485-493.
185. Issels R, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft tissue sarcoma. A randomised phase III multi-centre study of the EORTC-STBSG and the ESHO. Lancet Oncol 2010, 11(6):561-570.
186. Herman TS, Teicher BA Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma. Cancer Res 1988, 48(10):2693-2697.
187. Bornstein BA, Herman TS, Hansen JL, et al. Pilot study of local hyperthermia, radiation therapy, etanidazole, and cisplatin for advanced superficial tumours. Int J Hyperthermia 1995, 11(4):489-499.
188. Sugimachi K, Kitamura K, Baba K, et al. Hyperthermia combined with chemotherapy and irradiation for patients with carcinoma of the oesophagus-a prospective randomized trial. Int J Hyperthermia 1992, 8(3):289-295.
189. Jones EL, Samulski TV, Dewhirst MW, et al. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003, 98(2):277-282.
190. Westermann AM, Jones EL, Schem BC, et al. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma. Cancer 2005, 104(4):763-770.
191. Rau B, Wust P, Gellermann J, et al. [Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma]. Strahlenther Onkol 1998, 174(11):556-565.
192. Sneed PK, Dewhirst MW, Samulski T, et al. Should interstitial thermometry be used for deep hyperthermia? [Editorial; comment.]. Int J Radiat Oncol Biol Phys 1998, 40(5):1015-1017.
193. van der Zee J, Peer-Valstar JN, Rietveld PJ, et al. Practical limitations of interstitial thermometry during deep hyperthermia [see comments]. Int J Radiat Oncol Biol Phys 1998, 40(5):1205-1212.
194. Lagendijk JJ, Van Rhoon GC, Hornsleth SN, et al. ESHO quality assurance guidelines for regional hyperthermia. Int J Hyperthermia 1998, 14(2):125-133.
195. Dewhirst MW, Griffin TW, Smith AR, et al. Intersociety Council on Radiation Oncology essay on the introduction of new medical treatments into practice. J Natl Cancer Inst 1993, 85(12):951-957.
196. Emami B, Scott C, Perez CA, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys 1996, 34(5):1097-1104.
197. Perez CA, Gillespie B, Pajak T, et al. Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome. A Report by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1989, 16(3):551-558.
198. Perez CA, Pajak T, Emami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am J Clin Oncol 1991, 14(2):133-141.
199. Hand JW, Lagendijk JJ, Bach Andersen J, Bolomey JC Quality assurance guidelines for ESHO protocols. Int J Hyperthermia 1989, 5(4):421-428.
200. Engin K, Tupchong L, Moylan DJ, et al. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. Int J Hyperthermia 1993, 9(3):327-340.
201. Kapp DS, Petersen IA, Cox RS, et al. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses. Results of a randomized trial. Int J Radiat Oncol Biol Phys 1990, 19(6):1481-1495.
202. Thrall DE, Prescott DM, Samulski TV, et al. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiat Oncol Biol Phys 1996, 34(5):1087-1096.
203. Dewhirst MW, Poulson JM, Yu D, et al. Relation between pO2, 31-P MRS parameters and treatment outcome in patients with high grade soft tissue sarcomas (STS) treated with thermoradiotherapy. Int J Radiat Oncol Biol Phys 2005, 61(2):480-491.
204. Thrall DE, LaRue SM, Yu D, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005, 11(14):5206-5214.
205. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996, 35(4):731-744.
206. Datta NR, Bose AK, Kapoor HK, Gupta S Head and neck cancers. Results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia 1990, 6(3):479-486.
207. Valdagni R, Amichetti M, Pani G Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes. A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys 1988, 15(1):13-24.
208. Valdagni R, Amichetti M Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994, 28(1):163-169.
209. Sneed PK, Stauffer PR, McDermott MW, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998, 40(2):287-295.
210. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours. A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000, 355(9210):1119-1125.
211. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340(15):1154-1161.
212. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340(15):1137-1143.
213. Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000, 18(8):1606-1613.
214. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340(15):1144-1153.
215. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 1999, 17(5):1339-1348.
216. Colombo R, Da Pozzo LF, Salonia A, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003, 21(23):4270-4276.
217. Allen TM, Cullis PR Drug delivery systems. Entering the mainstream. Science 2004, 303(5665):1818-1822.
218. Mills JK, Needham D The materials engineering of temperature-sensitive liposomes. Methods Enzymol 2004, 387:82-113.
219. Chilkoti A, Dreher MR, Meyer DE Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Delivery Rev 2002, 54(8):1093-1111.
220. Liu XY, Ding XB, Guan Y, et al. Fabrication of temperature-sensitive imprinted polymer hydrogel. Macromol Biosci 2004, 4(4):412-415.
221. Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model. Importance of triggered drug release. Cancer Res 2000, 60(24):6950-6957.
222. Needham D, Anyarambhatla G, Kong G, Dewhirst MW A new temperature-sensitive liposome for use with mild hyperthermia. Characterization and testing in a human tumor xenograft model. Cancer Res 2000, 60(5):1197-1201.
223. Yarmolenko P, Zhao Y, Landon C, et al. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumors. Int J Hyperthermia 2010, 26(5):485-498.
224. Ponce AM, Viglianti BL, Yu D, et al. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst 2007, 99(1):53-63.
225. Viglianti BL, Abraham SA, Michelich CR, et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI. Illustration of targeted delivery. Magn Reson Med 2004, 51(6):1153-1162.
226. Viglianti BL, Ponce AM, Michelich CR, et al. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn Reson Med 2006, 56(5):1011-1018.
227. Roizin-Towle L, Pirro JP The response of human and rodent cells to hyperthermia. Int J Radiat Oncol Biol Phys 1991, 20(4):751-756.
228. Repasky E, Issels R Physiological consequences of hyperthermia. Heat, heat shock proteins and the immune response. Int J Hyperthermia 2002, 18(6):486-489.
229. Sapareto SA, Dewey WC Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984, 10(6):787-800.
230. Dewhirst MW, Viglianti BL, Lora-Michiels M Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 2003, 19(3):267-294.
231. Streffer C Metabolic changes during and after hyperthermia. Int J Hyperthermia 1985, 1(4):305-319.
232. Song CW Effect of local hyperthermia on blood flow and microenvironment. A review. Cancer Res 1984, 44(10 Suppl):4721s-4730s.
233. Kong G, Braun RD, Dewhirst MW Hyperthermia enables tumor-specific nanoparticle delivery. Effect of particle size. Cancer Res 2000, 60(16):4440-4445.
234. Dahl O Interaction of heat and drugs in vitro and in vivo. Thermoradiotherapy and thermochemotherapy 1995, 103-155. Springer-Verlag, Berlin. M. Seegenschmiedt, P. Fessenden, C. Vernon (Eds.).
235. Dreher MR, Liu W, Michelich CR, et al. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors. Cancer Res 2007, 67(9):4418-4424.
236. Oleson JR Eugene Robinson Special Lecture. Hyperthermia from the clinic to the laboratory: a hypothesis. Int J Hyperthermia 1995, 11(3):315-322.
237. Song CW, Park H, Griffin RJ Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001, 155(4):515-528.
238. Vujaskovic Z, Poulson J, Gaskin A, et al. Temperature dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia. Int J Radiat Oncol Biol Phys 2000, 46(1):179-185.
239. Gillette SM, Dewhirst MW, Gillette EL, et al. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia. A randomized phase II study. Int J Hyperthermia 1992, 8(3):309-320.
240. Overgaard J The current and potential role of hyperthermia in radiotherapy. Int J Radiat Oncol Biol Phys 1989, 16(3):535-549.
241. Dewhirst MW, Sim DA The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia. Cancer Res 1984, 44(10 Suppl):4772s-4780s.
242. Gillette EL, McChesney SL, Dewhirst MW, Scott RJ Response of canine oral carcinomas to heat and radiation. Int J Radiat Oncol Biol Phys 1987, 13(12):1861-1867.
243. Hettinga JV, Konings AW, Kampinga HH Reduction of cellular cisplatin resistance by hyperthermia-a review. Int J Hyperthermia 1997, 13(5):439-457.
244. Furusawa Y, Tabuchi Y, Takasaki I, et al. Gene networks involved in apoptosis induced by hyperthermia in human lymphoma U937 cells. Cell Biol Int 2009, 33(12):1253-1262.
245. Borkamo ED, Dahl O, Bruland O, Fluge O Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumor. Int J Hyperthermia 2009, 25(1):41-46.
246. Ostberg JR, Kabingu E, Repasky EA Thermal regulation of dendritic cell activation and migration from skin explants. Int J Hyperthermia 2007, 19(5):520-533.
247. Menoret A, Chaillot D, Callahan M, Jacquin C Hsp70, an immunological actor playing with the intracellular self under oxidative stress. Int J Hyperthermia 2002, 18:490-505.
248. Manjili MH, Wang XY, Park J, et al. Cancer immunotherapy. Stress proteins and hyperthermia. Int J Hyperthermia 2002, 18:506-520.
249. Multhoff G Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 2002, 18:576-585.
250. Shah A, Unger E, Bain MD, et al. Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermia. Int J Hyperthermia 2002, 18:534-551.
251. Hand JR Physical techniques in clinical hyperthermia 1986, John Wiley and Sons, New York.
252. Cossett JM Interstitial, endocavitary, and perfusional hyperthermia 1990, Springer-Verlag, Berlin.
253. Hynynen K Ultrasound heating technology. Thermoradiotherapy and thermochemotherapy 1995, 253-277. Springer-Verlag, Berlin, Heidelberg. M.H. Seegenschmiedt, P. Fessenden, C.C. Vernon (Eds.).
254. Stauffer PR Evolving technology for thermal therapy of cancer. Int J Hyperthermia 2005, 21(8):731-744.
255. Nadobny J, Wlodarczyk W, Westhoff L, et al. Development and evaluation of a three-dimensional hyperthermia applicator with Water-COated Antennas (WACOA). Med Phys 2003, 30(8):2052-2064.
256. Turner PF Regional hyperthermia with an annular phased array. IEEE Trans Biomed Eng 1984, 31:106-114.
257. Cetas TC Thermometry. An introduction to the practical aspects of clinical hyperthermia 1990, 423-477. Taylor & Francis, London, New York. S.B. Field, J.W. Hand (Eds.).
258. Dewhirst MW, Phillips TL, Samulski TV, et al. RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990, 18(5):1249-1259.
259. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 2005, 23(13):3079-3085.
260. McDannold N Quantitative MRI-based temperature mapping based on the proton resonant frequency shift. Review of validation studies. Int J Hyperthermia 2005, 21(6):533-546.
261. Cheng KS, Stakhursky V, Craciunescu OI, et al. Fast temperature optimization of multi-source hyperthermia applicators with reduced-order modeling of 'virtual sources. Phys Med Biol 2008, 53(6):1619-1635.
262. Gellerman J, Wlodarczyk W, Feussner A, et al. Methods and potentials of magnetic resonance imaging for monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia 2005, 21(6):497-513.
263. Rieke V, Butts PK MR thermometry. J Magn Reson Imaging 2008, 27(2):376-390.
264. Issels R, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft tissue sarcoma. A randomised phase III multi-centre study of the EORTC-STBSG and the ESHO. Lancet Oncol 2010, 11(6):561-570.
265. Sneed PK, Dewhirst MW, Samulski T, et al. Should interstitial thermometry be used for deep hyperthermia? [Editorial; comment.]. Int J Radiat Oncol Biol Phys 1998, 40(5):1015-1017.
266. Thrall DE, LaRue SM, Yu D, et al. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clin Cancer Res 2005, 11(14):5206-5214.
267. Vernon CC, Hand JW, Field SB, et al. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996, 35(4):731-744.
268. Valdagni R, Amichetti M Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 1994, 28(1):163-169.
269. Sneed PK, Stauffer PR, McDermott MW, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998, 40(2):287-295.
270. van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours. A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000, 355(9210):1119-1125.
271. Colombo R, Da Pozzo LF, Salonia A, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 2003, 21(23):4270-4276.
272. Chilkoti A, Dreher MR, Meyer DE Design of thermally responsive, recombinant polypeptide carriers for targeted drug delivery. Adv Drug Delivery Rev 2002, 54(8):1093-1111.
273. Kong G, Anyarambhatla G, Petros WP, et al. Efficacy of liposomes and hyperthermia in a human tumor xenograft model. Importance of triggered drug release. Cancer Res 2000, 60(24):6950-6957.
274. Needham D, Anyarambhatla G, Kong G, Dewhirst MW A new temperature-sensitive liposome for use with mild hyperthermia. Characterization and testing in a human tumor xenograft model. Cancer Res 2000, 60(5):1197-1201.
275. Ponce AM, Viglianti BL, Yu D, et al. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J Natl Cancer Inst 2007, 99(1):53-63.